[English] 日本語
Yorodumi- PDB-3wn5: Crystal structure of asymmetrically engineered Fc variant in comp... -
+Open data
-Basic information
Entry | Database: PDB / ID: 3wn5 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | Crystal structure of asymmetrically engineered Fc variant in complex with FcgRIIIa | |||||||||
Components |
| |||||||||
Keywords | IMMUNE SYSTEM / RECEPTOR COMPLEX / FC RECEPTOR / ANTIBODY | |||||||||
Function / homology | Function and homology information immune receptor activity / low-affinity IgG receptor activity / natural killer cell degranulation / IgG receptor activity / Fc-gamma receptor III complex / Fc-gamma receptor signaling pathway / macrophage activation / Fc-gamma receptor I complex binding / natural killer cell activation / complement-dependent cytotoxicity ...immune receptor activity / low-affinity IgG receptor activity / natural killer cell degranulation / IgG receptor activity / Fc-gamma receptor III complex / Fc-gamma receptor signaling pathway / macrophage activation / Fc-gamma receptor I complex binding / natural killer cell activation / complement-dependent cytotoxicity / IgG immunoglobulin complex / positive regulation of natural killer cell proliferation / antibody-dependent cellular cytotoxicity / IgG binding / natural killer cell mediated cytotoxicity / Classical antibody-mediated complement activation / Initial triggering of complement / immunoglobulin complex, circulating / immunoglobulin receptor binding / FCGR activation / Role of phospholipids in phagocytosis / complement activation, classical pathway / antigen binding / phosphatidylinositol 3-kinase/protein kinase B signal transduction / FCGR3A-mediated IL10 synthesis / Regulation of Complement cascade / FCGR3A-mediated phagocytosis / B cell receptor signaling pathway / calcium-mediated signaling / Regulation of actin dynamics for phagocytic cup formation / Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell / positive regulation of tumor necrosis factor production / antibacterial humoral response / Interleukin-4 and Interleukin-13 signaling / blood microparticle / adaptive immune response / cell surface receptor signaling pathway / immune response / external side of plasma membrane / extracellular space / extracellular exosome / extracellular region / plasma membrane Similarity search - Function | |||||||||
Biological species | Homo sapiens (human) | |||||||||
Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 2.78 Å | |||||||||
Authors | Kadono, S. / Mimoto, F. / Katada, H. / Igawa, T. / Kamikawa, T. / Hattori, K. | |||||||||
Citation | Journal: Mol.Immunol. / Year: 2014 Title: Crystal structure of a novel asymmetrically engineered Fc variant with improved affinity for Fc gamma Rs. Authors: Mimoto, F. / Kadono, S. / Katada, H. / Igawa, T. / Kamikawa, T. / Hattori, K. | |||||||||
History |
|
-Structure visualization
Structure viewer | Molecule: MolmilJmol/JSmol |
---|
-Downloads & links
-Download
PDBx/mmCIF format | 3wn5.cif.gz | 255.1 KB | Display | PDBx/mmCIF format |
---|---|---|---|---|
PDB format | pdb3wn5.ent.gz | 208.7 KB | Display | PDB format |
PDBx/mmJSON format | 3wn5.json.gz | Tree view | PDBx/mmJSON format | |
Others | Other downloads |
-Validation report
Summary document | 3wn5_validation.pdf.gz | 2.7 MB | Display | wwPDB validaton report |
---|---|---|---|---|
Full document | 3wn5_full_validation.pdf.gz | 2.7 MB | Display | |
Data in XML | 3wn5_validation.xml.gz | 43 KB | Display | |
Data in CIF | 3wn5_validation.cif.gz | 58.7 KB | Display | |
Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/wn/3wn5 ftp://data.pdbj.org/pub/pdb/validation_reports/wn/3wn5 | HTTPS FTP |
-Related structure data
Similar structure data |
---|
-Links
-Assembly
Deposited unit |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
2 |
| ||||||||
Unit cell |
|
-Components
-Ig gamma-1 chain C ... , 2 types, 4 molecules ADBE
#1: Protein | Mass: 25850.166 Da / Num. of mol.: 2 / Fragment: UNP RESIDUES 99-328 Mutation: C220S, D270E, K326D, A330K, K334E, D356C, T366S, L368A, Y407V Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: IGHG1 / Cell line (production host): HEK293F / Production host: Homo sapiens (human) / References: UniProt: P01857 #2: Protein | Mass: 26227.625 Da / Num. of mol.: 2 / Fragment: UNP RESIDUES 99-328 Mutation: C220S, L234Y, L235Y, G236W, S239M, H268D, S298A, A327D, Y349C, T366W Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: IGHG1 / Cell line (production host): HEK293F / Production host: Homo sapiens (human) / References: UniProt: P01857 |
---|
-Protein , 1 types, 2 molecules CF
#3: Protein | Mass: 22626.307 Da / Num. of mol.: 2 / Fragment: UNP RESIDUES 18-208 / Mutation: N35Q, N71Q, N166Q Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: FCGR3A, CD16A, FCG3, FCGR3, IGFR3 / Cell line (production host): HEK293F / Production host: Homo sapiens (human) / References: UniProt: P08637 |
---|
-Sugars , 5 types, 8 molecules
#4: Polysaccharide | Source method: isolated from a genetically manipulated source #5: Polysaccharide | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2- ...alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | Source method: isolated from a genetically manipulated source #6: Polysaccharide | Source method: isolated from a genetically manipulated source #7: Polysaccharide | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[2-acetamido-2-deoxy- ...2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose | Source method: isolated from a genetically manipulated source #9: Sugar | ChemComp-NAG / | |
---|
-Non-polymers , 2 types, 57 molecules
#8: Chemical | ChemComp-IOD / #10: Water | ChemComp-HOH / | |
---|
-Details
Sequence details | THE SEQUENCE CONFLICT VAL158 IS RELATED TO A NATURALLY OCCURRING VARIATION IN THE SEQUENCE OF HFCGIIIA |
---|
-Experimental details
-Experiment
Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
---|
-Sample preparation
Crystal | Density Matthews: 2.97 Å3/Da / Density % sol: 58.66 % |
---|---|
Crystal grow | Temperature: 293 K / pH: 6.25 Details: 14.5% PEG 3350, 0.1M Bis-Tris, 0.2M Sodium Iodide, Streak seeding, pH 6.25, VAPOR DIFFUSION, HANGING DROP, temperature 293K |
-Data collection
Diffraction | Mean temperature: 95 K |
---|---|
Diffraction source | Source: SYNCHROTRON / Site: Photon Factory / Beamline: AR-NE3A / Wavelength: 1 |
Detector | Type: ADSC QUANTUM 270 / Detector: CCD / Date: Feb 17, 2012 |
Radiation | Monochromator: DOUBLE CRYSTAL / Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
Radiation wavelength | Wavelength: 1 Å / Relative weight: 1 |
Reflection | Resolution: 2.78→49.03 Å / Num. obs: 43675 / % possible obs: 98 % / Observed criterion σ(I): -3 / Biso Wilson estimate: 51.96 Å2 / Rmerge(I) obs: 0.079 / Net I/σ(I): 13.91 |
Reflection shell | Resolution: 2.78→2.85 Å / Rmerge(I) obs: 0.619 / Mean I/σ(I) obs: 2.09 / % possible all: 98.2 |
-Processing
Software |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Refinement | Method to determine structure: MOLECULAR REPLACEMENT / Resolution: 2.78→25 Å / Cor.coef. Fo:Fc: 0.913 / Cor.coef. Fo:Fc free: 0.883 / Occupancy max: 1 / Occupancy min: 0.5 / SU B: 15.885 / SU ML: 0.308 / SU R Cruickshank DPI: 1.6987 / Cross valid method: THROUGHOUT / σ(F): 0 / ESU R: 1.699 / ESU R Free: 0.382 / Stereochemistry target values: MAXIMUM LIKELIHOOD / Details: U VALUES
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Solvent computation | Ion probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.2 Å / Solvent model: BABINET MODEL WITH MASK | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Displacement parameters | Biso mean: 54.66 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refinement step | Cycle: LAST / Resolution: 2.78→25 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refine LS restraints |
|